← Back to guidelines
Pathology56 papers

Deferred diagnosis on Axis I

Last edited: 4/15/2026

Overview

Deferred diagnosis on Axis I refers to the delayed identification and classification of mental health disorders under Axis I of the DSM (Diagnostic and Statistical Manual of Mental Disorders), impacting timely intervention and treatment 1.

Diagnosis

  • Importance of stakeholder input in prioritizing diagnostic criteria not explicitly detailed in provided abstracts 1.
  • No specific diagnostic tests or criteria outlined in the given abstracts for deferred diagnosis on Axis I 23.
  • Management

  • No specific first-line or adjunctive treatments mentioned for deferred Axis I diagnoses in the provided abstracts 23.
  • Special Populations

  • No specific considerations for pregnancy, pediatrics, elderly, or comorbidities related to deferred Axis I diagnoses are addressed in the provided abstracts 23.
  • Key Recommendations

  • Engage public stakeholders in weighting criteria for health research priorities to enhance relevance and urgency of mental health diagnostics 1 (Evidence: Expert opinion).
  • Implement systematic assessment methods for laboratory turnaround times to identify inefficiencies that may indirectly affect diagnostic processes 3 (Evidence: Moderate).
  • Prioritize the integration of novel diagnostic techniques into healthcare systems through effective commissioning strategies to ensure availability and accessibility 2 (Evidence: Expert opinion).
  • References

    1 Wazny K, Ravenscroft J, Chan KY, Bassani DG, Anderson N, Rudan I. Setting weights for fifteen CHNRI criteria at the global and regional level using public stakeholders: an Amazon Mechanical Turk study. Journal of global health 2019. link 2 Turner RD. Commissioning laboratory services. Molecular pathology : MP 2001. link 3 Smellie WS, Johnston J, Galloway PJ. Method for assessment of laboratory turnaround times: comparison before, during, and after analysis. Journal of clinical pathology 1994. link

    Original source

    1. [1]
      Setting weights for fifteen CHNRI criteria at the global and regional level using public stakeholders: an Amazon Mechanical Turk study.Wazny K, Ravenscroft J, Chan KY, Bassani DG, Anderson N, Rudan I Journal of global health (2019)
    2. [2]
      Commissioning laboratory services.Turner RD Molecular pathology : MP (2001)
    3. [3]
      Method for assessment of laboratory turnaround times: comparison before, during, and after analysis.Smellie WS, Johnston J, Galloway PJ Journal of clinical pathology (1994)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG